Julien Bally (0000-0002-0970-8844)

Personal information

Biography

Né à Morges, le Dr Julien Bally a grandi à Genève où il a obtenu son diplôme de médecin en janvier 2005. Après une formation en médecine générale, il intègre en 2009 le Service de neurologie des HUG (Genève), devient chef de clinique en 2013 et obtient son titre de spécialiste FMH en neurologie en 2014.

Dès 2010, sous la houlette du Professeur Pierre Pollak, pionnier de la stimulation cérébrale profonde, il découvre le monde passionnant des troubles du mouvements et rejoint en 2011 l’Unité des mouvements anormaux des HUG qui confirmera sa passion pour cette discipline. Désireux de parfaire sa formation, il effectue de 2015 à 2017 un fellowship clinique au Centre de recherche sur les mouvements anormaux du Toronto Western Hospital (Canada), sous la supervision directe du Professeur Anthony Lang, référence internationale dans le domaine.

Devenu spécialiste en mouvements anormaux (maladie de Parkinson, tremblements, dystonies et maladies apparentées), le Dr Bally réintègre les HUG pendant 3 ans avant de retourner sur ses terres ancestrales vaudoises après plus de 40 ans d’absence. En septembre 2020, il reprend la direction de l’unité des mouvements anormaux du CHUV en tant que médecin adjoint.

Activities

Collapse all

Université de Lausanne Faculté de biologie et de médecine: Lausanne, VD, CH

2020-09-01 to present | Docteur, Privat-Docent, Maître d'enseignement et de recherche clinique (Neurologie)

Employment

Julien Bally

https://orcid.org/0000-0002-0970-8844

Personal information

Countries

Biography

Activities

Employment (2)

Université de Lausanne Faculté de biologie et de médecine: Lausanne, VD, CH

Centre Hospitalier Universitaire Vaudois: Lausanne, CH

Education and qualifications (1)

Toronto Western Hospital: Toronto, Ontario, CA

Works (46)

Avoiding Misdiagnosis in Global Rostral Midbrain Syndrome (GRMS): Clinical Insights and Neurorehabilitation Approaches

Movement analysis in the diagnosis and management of Parkinson's disease.

Drug- and Toxin-Induced Opsoclonus – a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy

Concerns about efficacy of deep brain stimulation (DBS) in centromedian-parafascicular thalamic complex for rapid onset dystonia-parkinsonism (DYT12-ATP1A3).

[Neurology: what's new in 2023].

Deep Brain Stimulation Improves Parkinson's Disease-Associated Pain by Decreasing Spinal Nociception.

Exercise and gait/movement analyses in treatment and diagnosis of Parkinson's Disease.

A spinal cord neuroprosthesis for locomotor deficits due to Parkinson's disease.

[Tauopathy, motricity and cognition].

Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients.

[Neurology: what's new in 2022].

Impact of Subjective Evaluations in Predicting Response to Ventriculoperitoneal Shunt for Idiopathic Normal Pressure Hydrocephalus

Principles of gait encoding in the subthalamic nucleus of people with Parkinson's disease.

DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized Review

Genomic study of a large family with complex neurological phenotype including hearing loss, imbalance and action tremor

Implanted System for Orthostatic Hypotension in Multiple-System Atrophy

Recognizing myorhythmia 4 months after stroke - A teaching video.

[Neurology : what's new in 2021].

Consensus Statement on High-Intensity Focused Ultrasound for Functional Neurosurgery in Switzerland.

Towards adaptive deep brain stimulation: clinical and technical notes on a novel commercial device for chronic brain sensing.

DYT-TUBB4A (DYT4 Dystonia)

[Recent Advances in Neurology].

Oral Dysbiosis and Inflammation in Parkinson's Disease.

Isolated Ear Clicks with Partial Voluntary Control.

Complex movement disorder in a patient with heterozygous YY1 mutation (Gabriele-de Vries syndrome).

Modeling of Electric Fields in Individual Imaging Atlas for Capsular Threshold Prediction of Deep Brain Stimulation in Parkinson's Disease: A Pilot Study.

CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.

Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency? Response from the authors.

Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?

Une chorée sanglante

Une chorée tiqueuse

Predictive coding and adaptive behavior in patients with genetically determined cerebellar ataxia––A neurophysiology study

Patient-adjusted deep-brain stimulation programming is time saving in dystonia patients

Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.

Reader response: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease.

Systematic review of movement disorders and oculomotor abnormalities in Whipple's disease.

[Advanced Parkinson's disease : indication for complex treatments].

[Movement disorders emergencies].

Alcohol improves cerebellar learning deficit in myoclonus-dystonia: A clinical and electrophysiological investigation.

Localization of Deep Brain Stimulation Contacts Using Corticospinal/Corticobulbar Tracts Stimulation.

Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.

[Deep brain stimulation: new targets and new indications].

Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease.

"De mandibulae dysarthria"--thinking outside the box.

Crossed ataxia: a case report and a diffusion tensor imaging tractography study.

A palpable source of stroke.

Peer review (2 reviews for 1 publication/grant)